Nobiletin prevents cadmium-induced neuronal apoptosis by inhibiting reactive oxygen species and modulating JNK/ERK1/2 and Akt/mTOR networks in rats

Neurol Res. 2018 Mar;40(3):211-220. doi: 10.1080/01616412.2018.1424685. Epub 2018 Jan 16.

Abstract

Objectives Cadmium (Cd), an extremely noxious environmental pollutant is known to induce oxidative stress leading to neurodegenerative diseases. Nobiletin, a citrus flavonoid is reported to possess various pharmacological properties. This study investigates the effects of nobiletin over Cd-induced neuronal apoptosis in rodent experimental model. Methods To separate group of male Sprague Dawley rats, Cd (2 mL/kg/day) was subcutaneously injected for one month which results in a dose level of 1 mg/kg Cd. Couple of days prior to Cd injection, the treatment group rats regularly received nobiletin (50, 100, or 200 mg/kg b.wt) orally through the study period. Results Cd-induced ROS levels and malondialdehyde (MDA) content were inhibited by nobiletin and improved glutathione levels. Nobiletin reduced neuronal apoptosis induced by Cd and raised cleaved caspase-3 levels. Intriguingly, nobiletin blocked JNK and Erk1/2 phosphorylation and down-regulated the pathways. Raised expression of kinases - MKK and ASK1 were reduced by nobiletin. Discussion The suppressed expression of phosphatases - PP2A and PP5 were up-regulated on nobiletin treatment. Nobiletin significantly blocked the activation of Akt/mTOR signaling. Enhanced phosphorylation of S6K1, Akt, and 4E-BP1 induced by Cd was significantly inhibited by nobiletin. The raised levels of raptor and rictor proteins were remarkably down-regulated on nobiletin treatment. Collectively, the observations of this study indicate protective effects of nobiletin against Cd-induced neurotoxicity.

Keywords: Cadmium; MAPK signaling; mTOR; neurotoxicity; nobiletin.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Cadmium / toxicity
  • Caspase 3 / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Flavones / therapeutic use*
  • Glutathione / metabolism
  • In Situ Nick-End Labeling
  • MAP Kinase Kinase 4 / metabolism
  • Male
  • Malondialdehyde / metabolism
  • Neurodegenerative Diseases / chemically induced
  • Neurodegenerative Diseases / prevention & control*
  • Neurons / drug effects
  • Neurons / pathology
  • Neuroprotective Agents / therapeutic use*
  • Oncogene Protein v-akt / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction / drug effects*

Substances

  • Enzyme Inhibitors
  • Flavones
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • Cadmium
  • Malondialdehyde
  • nobiletin
  • Oncogene Protein v-akt
  • MAP Kinase Kinase 4
  • Caspase 3
  • Glutathione